Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2019) [Effective from January 1, 2019]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2017: 100.00
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2017: 100.00
NAAS RATING 2018: 5.38

Int.J.Curr.Microbiol.App.Sci.2018.7(2): 1270-1281
DOI: https://doi.org/10.20546/ijcmas.2018.702.155


Multi-drug Resistance and Extended-Spectrum β-Lactamase Production in Uropathogens from Hospitalized Patients in Gurugram, India
Rishabh Rajput1,2* and Surendra Sarsaiya1,3
1Department of Microbiology, Sri Satya Sai University of Technology and Medical Sciences, Sehore-Madhya Pradesh, India
2Department of Microbiology, Modern Diagnostic & Research Centre, Gurugram, Haryana, India
3Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China
*Corresponding author
Abstract:

Urinary tract infections (UTI) are one of the most frequent problems in hospitalized patients. Infections caused by the gram-negative bacteria which produces Extended-spectrum β-lactamases (ESBL) have become the severe problem in the hospitals across the globe. Increase in extended-spectrum beta-lactamase producing organisms in recent years has led to the limitation of treatment option. This study was designed to evaluate the occurrence of different uropathogens producing ESBL, its antibiogram and Multi-drug resistance (MDR) status in hospitalized patients. 885 non-repetitive urine samples were collected in the study. A total of 293 (33.11%) samples showed significant bacteriuria. Females were found to be more infected as compared to males. The senior citizens were found to be most affected (>60 years). The most common ESBL producing uropathogens were Escherichia coli (E. coli) followed by Klebsiella pneumoniae (K. pneumoniae). All the ESBL positive isolates were found to be MDR. The prevalence of MDR was also significantly increased due to ESBL production. The monitoring of antibiotic resistance and susceptibility of bacterial strains should be mandatory due to the higher frequency of the ESBL producing uropathogens found in the hospitalized patients. It was proved in this study that the multi-drug resistance was responsible for the significant treatment failure. Hence testing of ESBL production in the uropathogens is warranted. It is also suggested not to prescribe any antibiotics without undertaking the culture and sensitivity report as it may further erode the antibiotics sensitivity in the studied regional population.


Keywords: UTI, Multi-drug resistance, Extended-Spectrum β-lactamase, ESBL, E. coli, K. pneumoniae, CLSI, ATCC,
Download this article as Download

How to cite this article:

Rishabh Rajput and Surendra Sarsaiya. 2018. Multi-drug Resistance and Extended-Spectrum β-Lactamase Production in Uropathogens from Hospitalized Patients in Gurugram, India.Int.J.Curr.Microbiol.App.Sci. 7(2): 1270-1281. doi: https://doi.org/10.20546/ijcmas.2018.702.155